Other Treatments Archives - Page 2 of 6 - Sperling Prostate Center

A Case Study of Recurrent Prostate Cancer after Proton Beam Therapy

When the National Cancer Institute (NCI) publishes a case study in prostate cancer (PCa) treatment, it’s an experience in very respectable clinical detail. An example is the 2015 analysis of one man’s recurrent PCa following primary (first) prostate cancer treatment with proton beam radiation. The study, “Upgrading Prostate Cancer Following Proton Beam Therapy,”[i] includes co-author keep reading

Calypso: Can Radiation Treatment be Improved?

If you look at an illustration of where the prostate gland is located, it’s easy to find. It’s nestled below and against the bladder, and sits in front of the rectal wall (with a layer of tissue in between). Seeing the illustration, your unconscious mind takes for granted that’s where the prostate always stays. However, keep reading

Cannabis and Prostate Cancer

Cannabis (marijuana, pot, weed, grass etc.) is a widely used recreational and medicinal drug. In fact, cannabis use dates far back in ancient times, probably for the same two purposes. Today, state laws in the U.S. are rapidly becoming more permissive less than a century after it was made illegal in 1937. According to Ramos keep reading

Treating Prostate Cancer Bone Mets with Radium-223

It is always thrilling when a treatment is working so well in a clinical trial that the study ends early and the FDA moves rapidly with approval. This was the case with a clinical study called ALSYMPCA (Alpharadin in Symptomatic Prostate Cancer Patients). The purpose of this Phase III trial was to compare the effectiveness keep reading

Multiparametric MRI Predicts Recurrence After Prostatectomy

Let’s pretend that you are a prostate cancer patient whose doctor, a well-known robotic surgeon, recommends robotic-assisted radical prostatectomy (RRP). He makes some very persuasive points: Based on the Partin tables you have less than a 12% chance of biochemical recurrence (rising PSA) in three years after treatment. He’ll “get it all out” and you keep reading

“Smart” Bomb Against Prostate Cancer: Lutetium-177

In 1991, Operation Desert Storm brought the first large-scale use of missile-type bombs that carried precision guidance systems, or “smart” bombs. Since these munitions could hit targets with great accuracy, collateral damage to civilians and civilian structures was greatly reduced. Now there is a new approach using smart bomb principles to treating metastatic prostate cancer keep reading

Another Reason Reconsider Radiation Treatment: Low Testosterone

Men with localized prostate cancer (PCa) are usually given three treatment choices: radical prostatectomy (RP), external beam radiation therapy (EBRT) or Active Surveillance (AS). Although patients are rarely told about minimal-to-noninvasive treatments that can be applied as focal therapy, it’s somewhat heartening that urologists and radiologists are increasingly supportive of AS for low-risk patients. This keep reading

Quality of Life Differences after Prostate Cancer Treatment

Reviews and ratings are very important in today’s world. Look at the internet. Whether it’s Yelp, Amazon, Ebay, Angie’s List or hundreds more, the number of stars or thumbs up are not as influential as the qualitative comments left by consumers. In similar fashion, radical prostatectomy is still upheld as the “gold standard” (click for keep reading

Prostate Cancer Drugs Are Linked to Dementia

Men need testosterone, but prostate cancer does not. While there is new evidence that use of testosterone replacement therapy does not lead to prostate cancer, once prostate cancer has occurred, it appears to be fueled by testosterone. This is particularly bad news if prostate cancer has penetrated the edges of the gland capsule and begun keep reading

How Additional Treatments after Prostatectomy Affect Quality of Life

In the urologic world, there is a longstanding bias that surgical removal of the prostate gland, or radical prostatectomy (RP), is the preferred treatment for prostate cancer (PCa). It is based in the outdated belief that all PCa is a) multifocal, and b) likely to spread beyond the gland if untreated. Thus, it seemed logical keep reading

Category: Other Treatments